venBio Select Advisor »

Crispr Therapeutics shares owned by venBio Select Advisor

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by venBio Select Advisor from 13F filings

Historical chart of venBio Select Advisor investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by venBio Select Advisor consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by venBio Select Advisor

Quarter filed Position value Share count Share price at filing
2024-03-31 $29M 420k 68.16
2018-09-30 $6.5M 147k 44.35

More positions owned by venBio Select Advisor

United Therapeutics Corp Common (UTHR)
Apellis Pharmaceuticals Common (APLS)
Ascendis Pharma Sponsored ADR (ASND)
Sarepta Therapeutics Common (SRPT)
Madrigal Pharmaceuticals Common (MDGL)
Argenx Se Sponsored ADR (ARGX)
Krystal Biotech Common (KRYS)
Spdr Series Trust - S&p Biotech Etf (XBI)
Biomarin Pharmaceutical Common (BMRN)
Amicus Therapeutics Common (FOLD)
Cerevel Therapeutics Hldng Common (CERE)
Viking Therapeutics Common (VKTX)
Arrowhead Pharmaceuticals Common (ARWR)
Xenon Pharmaceuticals Common (XENE)
Alpine Immune Sciences Common

View all positions for venBio Select Advisor

Top funds holding Crispr Therapeutics

Capital Research and Management Company - Division 3
ARK Investment Management
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
BlackRock
BlackRock
T. Rowe Price Investment Management
State Street Corporation
Vanguard Group
NEA Management Company
Citadel Advisors
EcoR1 Capital
Susquehanna International
Bank of America Corporation
Sr One Capital Management

View all funds holding Crispr Therapeutics